[fusion_builder_container type=»flex» hundred_percent=»yes» hundred_percent_height=»no» min_height=»» hundred_percent_height_scroll=»no» align_content=»stretch» flex_align_items=»flex-start» flex_justify_content=»flex-start» flex_column_spacing=»» hundred_percent_height_center_content=»yes» equal_height_columns=»no» container_tag=»div» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» status=»published» publish_date=»» class=»» id=»» margin_top_medium=»» margin_bottom_medium=»» margin_top_small=»» margin_bottom_small=»» margin_top=»» margin_bottom=»» padding_top_medium=»» padding_right_medium=»» padding_bottom_medium=»» padding_left_medium=»» padding_top_small=»» padding_right_small=»0px» padding_bottom_small=»» padding_left_small=»0px» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»» link_color=»» link_hover_color=»» border_sizes_top=»» border_sizes_right=»» border_sizes_bottom=»» border_sizes_left=»» border_color=»» border_style=»solid» box_shadow=»no» box_shadow_vertical=»» box_shadow_horizontal=»» box_shadow_blur=»0″ box_shadow_spread=»0″ box_shadow_color=»» box_shadow_style=»» z_index=»» overflow=»» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ background_blend_mode=»none» video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» render_logics=»» absolute=»off» absolute_devices=»small,medium,large» sticky=»off» sticky_devices=»small-visibility,medium-visibility,large-visibility» sticky_background_color=»» sticky_height=»» sticky_offset=»» sticky_transition_offset=»0″ scroll_offset=»0″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″ admin_label=»Factor News Post»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»2_3″ align_self=»auto» content_layout=»column» align_content=»flex-start» valign_content=»flex-start» content_wrap=»wrap» spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» type_medium=»» type_small=»» order_medium=»0″ order_small=»0″ dimension_spacing_medium=»» dimension_spacing_small=»» dimension_spacing=»» dimension_margin_medium=»» dimension_margin_small=»» margin_top=»» margin_bottom=»» padding_medium=»» padding_small=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»» hover_type=»none» border_sizes=»» border_color=»» border_style=»solid» border_radius=»» box_shadow=»no» dimension_box_shadow=»» box_shadow_blur=»0″ box_shadow_spread=»0″ box_shadow_color=»» box_shadow_style=»» background_type=»single» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ background_color=»» background_image=»» background_image_id=»» background_position=»left top» background_repeat=»no-repeat» background_blend_mode=»none» render_logics=»» filter_type=»regular» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» last=»true» border_position=»all» first=»true» spacing_right=»»][fusion_imageframe image_id=»4426|full» max_width=»» sticky_max_width=»» skip_lazy_load=»» style_type=»» blur=»» stylecolor=»» hover_type=»none» bordersize=»» bordercolor=»» borderradius=»» align_medium=»none» align_small=»none» align=»none» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» lightbox=»no» gallery_id=»» lightbox_image=»» lightbox_image_id=»» alt=»» link=»» linktarget=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″]https://factoronline.mx/wp-content/uploads/2021/08/236718753_229496265845004_5099317736942000359_n.jpg[/fusion_imageframe][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»20px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_title title_type=»text» rotation_effect=»bounceIn» display_time=»1200″ highlight_effect=»circle» loop_animation=»off» highlight_width=»9″ highlight_top_margin=»0″ before_text=»» rotation_text=»» highlight_text=»» after_text=»» title_link=»off» link_url=»» link_target=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» content_align_medium=»» content_align_small=»» content_align=»center» size=»1″ font_size=»» animated_font_size=»» fusion_font_family_title_font=»» fusion_font_variant_title_font=»» line_height=»» letter_spacing=»» text_shadow=»no» text_shadow_vertical=»» text_shadow_horizontal=»» text_shadow_blur=»0″ text_shadow_color=»» margin_top_medium=»» margin_right_medium=»» margin_bottom_medium=»» margin_left_medium=»» margin_top_small=»» margin_right_small=»» margin_bottom_small=»» margin_left_small=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» margin_top_mobile=»» margin_bottom_mobile=»» text_color=»#1968a3″ animated_text_color=»» gradient_font=»no» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ highlight_color=»» style_type=»default» sep_color=»» link_color=»» link_hover_color=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]
Israel – 12/Ago/2021
[/fusion_title][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»50px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_text columns=»» column_min_width=»» column_spacing=»» rule_style=»default» rule_size=»» rule_color=»» content_alignment_medium=»» content_alignment_small=»» content_alignment=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» font_size=»» fusion_font_family_text_font=»» fusion_font_variant_text_font=»» line_height=»» letter_spacing=»» text_color=»#000000″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]
Un nuevo medicamento desarrollado en Israel curó en 5 días a pacientes graves de Covid-19, de acuerdo con datos de un ensayo clínico fase 2, informó The Jerusalem Post.
Se trata del medicamento EXO-CD24, desarrollado por el Centro Médico Sourasky de Tel Aviv, Israel, el cual se encuentra en pruebas y finalizó el ensayo clínico fase 2.
En el ensayo clínico fase 2, a 90 pacientes graves de coronavirus tratados en varios hospitales griegos se les aplicó el nuevo medicamento EXO-CD24.
Los resultados del ensayo clínico arrojaron que el 93 por ciento de los pacientes graves con Covid-19, fueron dados de alta en cinco días o menos, tras tomar el nuevo medicamento, Además, hasta el momento no se ha registrado que ningún paciente haya tenido algún efecto secundario significativo, dijo el profesor Nadir Arber.
El estudio clínico fase 2 se llevó a cabo en Atenas, Grecia, debido a que en Israel no habían pacientes graves de Covid-19, de acuerdo con The Jerusalem Post.
El científico explicó que la principal causa del deterioro clínico de los pacientes es una sobreactuación del sistema inmunológico, también conocida como tormenta de citocinas.
[/fusion_text][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»50px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_title title_type=»text» rotation_effect=»bounceIn» display_time=»1200″ highlight_effect=»circle» loop_animation=»off» highlight_width=»9″ highlight_top_margin=»0″ before_text=»» rotation_text=»» highlight_text=»» after_text=»» title_link=»off» link_url=»» link_target=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» content_align_medium=»» content_align_small=»» content_align=»center» size=»1″ font_size=»40px» animated_font_size=»» fusion_font_family_title_font=»» fusion_font_variant_title_font=»» line_height=»» letter_spacing=»» text_shadow=»no» text_shadow_vertical=»» text_shadow_horizontal=»» text_shadow_blur=»0″ text_shadow_color=»» margin_top_medium=»» margin_right_medium=»» margin_bottom_medium=»» margin_left_medium=»» margin_top_small=»» margin_right_small=»» margin_bottom_small=»» margin_left_small=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» margin_top_mobile=»» margin_bottom_mobile=»» text_color=»#000000″ animated_text_color=»» highlight_color=»» style_type=»default» sep_color=»» link_color=»» link_hover_color=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]
¡Síguenos en nuestras redes sociales!
[/fusion_title][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»30px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_social_links blogger=»» deviantart=»» discord=»» digg=»» dribbble=»» dropbox=»» facebook=»https://www.facebook.com/Factor-News-106400478154584″ flickr=»» forrst=»» instagram=»https://instagram.com/factoronline2021/» linkedin=»» myspace=»» paypal=»» pinterest=»» reddit=»» rss=»» skype=»» soundcloud=»» spotify=»» tiktok=»» tumblr=»» twitch=»» twitter=»https://twitter.com/FactorNews2020″ vimeo=»» vk=»» wechat=»» whatsapp=»» xing=»» yahoo=»» yelp=»» youtube=»» email=»» phone=»» show_custom=»no» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» font_size=»35px» icons_boxed=»yes» icons_boxed_radius=»50px» color_type=»custom» icon_colors=»#ffffff» box_colors=»#ffd330″ tooltip_placement=»» alignment=»center» /][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
